Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia- A Cost-Effectiveness Analysis

May 1, 2015, 00:00
10.1016/j.jval.2015.03.1176
https://www.valueinhealthjournal.com/article/S1098-3015(15)01233-4/fulltext
Title : Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia- A Cost-Effectiveness Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01233-4&doi=10.1016/j.jval.2015.03.1176
First page : A203
Section Title : Cancer
Open access? : No
Section Order : 638
Categories :
Tags :
Regions :
ViH Article Tags :